Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Cumberland Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2031 | $44.85M | $44.85M - $44.85M | $966.7K | -$0.23 | 1 |
| Dec 2030 | $40.97M | $40.97M - $40.97M | $882.9K | -$0.03 | 1 |
| Dec 2029 | $36.96M | $36.96M - $36.96M | $796.6K | -$0.22 | 1 |
| Dec 2028 | $45.20M | $45.20M - $45.20M | $974.1K | -$0.31 | 1 |
| Dec 2027 | $38.23M | $38.23M - $38.23M | $823.8K | -$0.55 | 1 |
| Dec 2026 | $38.23M | $38.23M - $38.23M | $823.8K | -$0.55 | 1 |
| Dec 2024 | $44.85M | $44.85M - $44.85M | $966.7K | -$0.23 | 1 |
| Dec 2023 | $44.85M | $44.85M - $44.85M | $7.88M | -$0.23 | 1 |
| Dec 2022 | $40.97M | $40.97M - $40.97M | $6.86M | -$0.03 | 12 |
| Dec 2021 | $36.96M | $36.96M - $36.96M | $6.47M | -$0.22 | 9 |
| Dec 2020 | $45.20M | $45.20M - $45.20M | $91.7K | -$0.31 | 11 |
| Dec 2019 | $38.23M | $38.23M - $38.23M | $77.5K | -$0.55 | 8 |